Pahuja D N, Jagtap V S, Sonawane V R, Rajan M G R, Samuel A M
Laboratory Nuclear Medicine Section (Isotope Group, B.A.R.C.), Tata Memorial Hospital Annexe, Bhabba Atomic Research Center, Parel, Mumbai 400 012, India.
Health Phys. 2005 Jul;89(1):92-4. doi: 10.1097/01.hp.0000156954.85743.fa.
KI and KIO3 are the commonly used prophylactic drugs for the protection of thyroid glands against radioiodine. In this study, we have demonstrated the use of another iodine containing salt, calcium iodate [Ca(IO3)2], as an effective blocker of radioiodine uptake by the thyroid gland in rats. Ca(IO3)2 is permitted by the FDA as a food additive and is "generally regarded as safe" (GRAS, CFR No.1206). We have also compared the efficacy of Ca(IO3)2 with KIO3 in blocking thyroidal uptake of radioiodine, which could be important considering the better shelf life of Ca(IO3)2. Laboratory rats were administered 131I and stable iodide in the form of KIO3 or Ca(IO3)2 was given orally, 2 h after the administration of 131I. All the animals were monitored for whole body retention (WBR) of 131I, at 24 h and further for 14 d. The results of the present study provide us with evidence that Ca(IO3)2 can serve as another promising radioiodine blocker, and is as equipotent as KI/KIO3 in protecting the thyroid gland. We have not found any studies that examined the property of Ca(IO3)2 in blocking radioiodine uptake by the thyroid gland and the present study is an attempt in this direction.
碘化钾(KI)和碘酸钾(KIO₃)是常用的预防药物,用于保护甲状腺免受放射性碘的侵害。在本研究中,我们证明了另一种含碘盐碘酸钙[Ca(IO₃)₂]可作为大鼠甲状腺摄取放射性碘的有效阻滞剂。碘酸钙被美国食品药品监督管理局(FDA)批准为食品添加剂,并且“一般认为是安全的”(GRAS,联邦法规编号1206)。我们还比较了碘酸钙与碘酸钾在阻断甲状腺摄取放射性碘方面的功效,考虑到碘酸钙具有更好的保质期,这一点可能很重要。给实验大鼠注射¹³¹I,在注射¹³¹I 2小时后口服稳定碘形式的碘酸钾或碘酸钙。在24小时及之后的14天内监测所有动物体内¹³¹I的全身滞留量(WBR)。本研究结果为我们提供了证据,表明碘酸钙可作为另一种有前景的放射性碘阻滞剂,在保护甲状腺方面与碘化钾/碘酸钾等效。我们尚未发现任何研究考察碘酸钙阻断甲状腺摄取放射性碘的特性,本研究是朝这个方向进行的一次尝试。